Country: Bretland
Tungumál: enska
Heimild: MHRA (Medicines & Healthcare Products Regulatory Agency)
Ferrous gluconate
Arrow Generics Ltd
B03AA03
Ferrous gluconate
300mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 09010101; GTIN: 5060034830924
PATIENT INFORMATION LEAFLET FERROUS GLUCONATE 300MG TABLETS READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. ALWAYS TAKE THIS MEDICINE EXACTLY AS DESCRIBED IN THIS LEAFLET OR AS YOUR DOCTOR OR PHARMACIST HAS TOLD YOU. • KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN. • IF YOU HAVE ANY FURTHER QUESTIONS, ASK YOUR DOCTOR OR PHARMACIST. • THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU ONLY. DO NOT PASS IT ON TO OTHERS. IT MAY HARM THEM, EVEN IF THEIR SIGNS OF ILLNESS ARE THE SAME AS YOURS. • IF YOU GET ANY SIDE EFFECTS TALK TO YOUR DOCTOR OR PHARMACIST. THIS INCLUDES ANY POSSIBLE SIDE EFFECTS NOT LISTED IN THIS LEAFLET. SEE SECTION 4. • YOU MUST TALK TO A DOCTOR IF YOU DO NOT FEEL BETTER OR IF YOU FEEL WORSE. WHAT IS IN THIS LEAFLET 1. What Ferrous Gluconate 300mg Tablets are and what they are used for 2. What you need to know before you take Ferrous Gluconate 300mg Tablets 3. How to take Ferrous Gluconate 300mg Tablets 4. Possible side effects 5. How to store Ferrous Gluconate 300mg Tablets 6. Contents of the pack and other information PRODUCT: PLEASE SIGN PL HOLDER: _ _____________________________ PRINTER: _ ________________________________ PACKING SITE: ____________________________ PROOF NO & DATE Proof for submission to MHRA Colours CUSTOMER: SP DESIGNER: MAT (AWG) PRODUCT: Ferrous Gluconate 300mg Tablets ITEM CODE: CP.FGL.300T.SP.V3P1 PROOF NO AND DATE: 2 19/02/2018 REVISION: ARTWORK FOR SUBMISSION Supersedes: CP.FGL.300T.SP.V2P3 Pantone Blue 280 C DIMENSIONS: 146mm x 350mm CP.FGL.300T.SP.V3P1 1. 2. WHAT FERROUS GLUCONATE 300MG TABLETS ARE AND WHAT THEY ARE USED FOR Ferrous Gluconate 300mg Tablets are used for the treatment and prevention of iron deficiency. Ferrous Gluconate is a form of iron. Iron is necessary for the production of haemoglobin (protein in red blood cells), which carries oxygen around the body. Iron is involved in the formation of myoglobin, a pigment that stores oxygen in muscles for use during exercise. WHAT YO Lestu allt skjalið
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ferrous Gluconate 300 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 300 mg of Ferrous Gluconate. Excipients of known effect: Each tablet also contains 168.2 mg of Sucrose and 2.7 mg of Liquid glucose. For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Tablet A dark-red, smooth, polished tablet with a slight odour. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ferrous Gluconate 300 mg Tablets is indicated for the prevention and treatment of iron deficiency states. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY: Adults and the elderly: Prophylactic: 2 tablets daily. Therapeutic: 4 to 6 tablets daily in divided doses. Children (aged 6-l2 years): Prophylactic: 1 or 2 tablets daily Therapeutic: 3 tablets daily in divided doses These tablets are best taken about one hour before meals. METHOD OF ADMINISTRATION: The route of administration for Ferrous Gluconate 300 mg tablets is oral. 4.3 CONTRAINDICATIONS • Hypersensitivity to the active ingredient Ferrous gluconate or to any of the excipients listed in section 6.1. • Iron preparations are contra-indicated in patients with haemochromatosis, iron storage or absorption diseases such as and haemosiderosis or haemoglobinuria. • Iron is contraindicated in patients receiving repeated blood transfusions, or in patients receiving parenteral iron therapy or to patients with anaemias not produced by iron deficiency (some conditions, such as thalassemia may cause excess storage of iron). • Alcoholism and hepatitis. • Iron preparations are contraindicated in active peptic ulcer, regional enteritis and ulcerative colitis. • Ferrous Gluconate Tablets should not be used in patients with anaemia not produced by iron deficiency unless iron deficiency is also present. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Large doses may have irritant/ corrosive effect on gastro-intestinal mucosa which can lead to necrosis and perforation. Ferrous Gluconate shou Lestu allt skjalið